Lifecore Biomedical (LFCR) news
Recent news
Lifecore Biomedical - Contract manufacturing agreement term extended to December 31, 2034 - SEC filing
Lifecore Biomedical has announced an extension of its contract manufacturing agreement, with the terms now set to remain in effect until December 31, 2034. The extension was disclosed in a recent SEC filing, reflecting the company’s ongoing efforts to secure long-term operational stability and…
AInvest Wire · Sep 29, 2026Lifecore Biomedical - Unit enters amendment no. 3 to contract manufacturing agreement with Alcon effective Nov 1, 2026 - SEC filing
AInvest Wire · Sep 29, 2026Lifecore Biomedical, Inc.: Barrington Research cuts to market perform from outperform
Barrington Research analyst Michael Petusky has downgraded Lifecore Biomedical, Inc. (NASDAQ: LFCR) from "Outperform" to "Market Outperform," citing recent developments in the company's financial performance and strategic outlook. The move reflects a recalibration of expectations amid evolving…
AInvest Wire · Sep 29, 2026Trading released/resumed: (LFCR) Reason not available
Trading in shares of Lifecore Biomedical Inc. (LFCR) was reported as resumed on September 28, 2026 , according to market updates. As of 9:56 AM EDT, the stock was active in the market, though no specific price or volume data was provided in the available sources. The resumption of trading followed…
AInvest Wire · Sep 28, 2026Webster Equity to buy LFCR for $6.28/shr cash plus CVR
AInvest Wire · Sep 28, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.